As New Jersey’s only NCI-designated Comprehensive Cancer Center, Rutgers Cancer Institute of New Jersey together with RWJBarnabas Health, provides patients access to the most advanced treatment options including complex surgical procedures, sophisticated radiation therapy techniques, innovative clinical trials, immunotherapy, and precision medicine.
|
|
|
Examining SARS-CoV2 in a Radiation Oncology Clinic |
|
|
|
It has been hypothesized that SARS-CoV2, the virus that causes COVID-19, may contaminate surfaces and objects via droplets from the mouth or nose. A new study led by radiation oncology resident Imraan Jan, DO, at Rutgers Robert Wood Johnson Medical School, and Bruce G. Haffty, MD, associate vice chancellor for cancer programs and chair, radiation oncology at Rutgers Cancer Institute of New Jersey focused on environmental surface testing. The swabbing took place at the center’s Radiation Oncology Department located within Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, during the height of the COVID-19 pandemic in the state and showed no detectable SARS-CoV2. Learn more
|
|
$4.6 Million National Institutes of Health Grant Supports Exploration of “Chemo Brain” in Children |
|
|
|
Some pediatric cancer survivors experience cognitive impairment that impacts sensory processing, memory and attention. This is widely known as “chemo brain.” A new study led by Peter Cole, MD, chief of pediatric hematology/oncology at Rutgers Cancer Institute in partnership with researchers at Albert Einstein College of Medicine, Children’s Hospital at Montefiore will explore how chemotherapy for children with acute lymphoblastic leukemia (ALL) affects children’s cognitive development. The aim is to learn how to reduce these late effects. Learn more
|
|
New Oncologic Quality Leader Named to Rutgers Cancer Institute and Robert Wood Johnson University Hospital |
|
|
|
Henry A. Pitt, MD, has recently been appointed as Chief of Oncologic Quality at Rutgers Cancer Institute of New Jersey and Robert Wood Johnson University Hospital, an RWJBarnabas Health facility. In this new role, he will provide leadership and oversight for the planning and execution of initiatives in the areas of quality improvement, performance excellence, patient safety, patient satisfaction, infection control, and outcomes reporting. Learn more about Dr. Pitt.
|
|
Exploring a Novel Approach to Accelerate Treatment Testing for Common Brain Tumor |
|
|
|
A common brain tumor, glioblastoma multiforme, is deadly even with the best current therapies. Patient-derived models are needed to rapidly predict treatment responses and test new and combined therapies. Rutgers Cancer Institute resident research member and associate professor of medicine and pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School Hatem E. Sabaawy, MD, PhD, and colleagues have developed a novel method to address this. The approach utilizes 4-dimensional printing of arrays that transform from cell-culture inserts into histological cassettes that hold patient tissue samples for rapid programmable drug testing. Learn more
|
|
|
|
|
|
|
